Fulgent Genetics: Q3 Earnings Insights - Fulgent Genetics (NASDAQ:FLGT)

Fulgent Genetics FLGT reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM.

Here's what investors need to know about the announcement.

Fulgent Genetics their estimated earnings by 24.62%, reporting an EPS of $4.05 versus an estimate of $3.25, which surprised analysts.

Revenue was up $126,152,000 from the same period last year.

Last quarter the company missed on EPS by $0.26, which was followed by a 11.32% drop in the share price the next day.

Here's a look at Fulgent Genetics's past performance:

Quarter	Q2 2021	Q1 2021	Q4 2020	Q3 2020
EPS Estimate	2.81	5.86	4.05	0.55
EPS Actual	2.55	6.59	6.20	2.08
Revenue Estimate	197.34M	321.51M	199.44M	48.46M
Revenue Actual	153.62M	359.43M	294.98M	101.72M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.